Mortality results from a randomized prostate-cancer screening trial (Q24601536)

Timothy R Church

6

0 references

Saundra S. Buys

4

Saundra S Buys

0 references

Paul F Pinsky

21

Paul F Pinsky

0 references

Christine Berg

24

Christine D Berg

0 references

Barnett S. Kramer

18

Barnett S Kramer

0 references

John K Gohagan

23

John K Gohagan

0 references

author name string

Gerald L Andriole

1

0 references

E David Crawford

2

0 references

Robert L Grubb

3

0 references

David Chia

5

0 references

Mona N Fouad

7

0 references

Edward P Gelmann

8

0 references

Paul A Kvale

9

0 references

Douglas J Reding

10

0 references

Joel L Weissfeld

11

0 references

Lance A Yokochi

12

0 references

Barbara O'Brien

13

0 references

Joshua M Rathmell

15

0 references

Thomas L Riley

16

0 references

Richard B Hayes

17

0 references

Grant Izmirlian

19

0 references

Anthony B Miller

20

0 references

Philip C Prorok

The New England Journal of Medicine

22

0 references

language of work or name

English

0 references

publication date

26 March 2009

0 references

published in

0 references

volume

360

0 references

issue

13

0 references

page(s)

1310-9

0 references

cites work

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Radical prostatectomy versus watchful waiting in early prostate cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

20-year outcomes following conservative management of clinically localized prostate cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

The role of increasing detection in the rising incidence of prostate cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944770

Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay

28 November 2018

1 reference

12 December 2020

Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA)

1 reference

12 December 2020

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

12 December 2020

Studies of prostate-cancer mortality: caution advised

1 reference

12 December 2020

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

12 December 2020

NCCN clinical practice guidelines in oncology: prostate cancer early detection

1 reference

12 December 2020

Infection after transrectal core biopsies of the prostate--risk factors and antibiotic prophylaxis

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMOA0810696

1 reference

release_n2avyrpb3vcbnepylegvqfoqey

1735220

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n2avyrpb3vcbnepylegvqfoqey

24 November 2022

mapped directly with Wikidata item

1735220

1 reference

1 reference

1 reference